Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 4, Issue 1, Supplement 1 , Pages S56-S59 , January 2008

The oldest old and the 90+ Study

  • Claudia H. Kawas

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: 949-824-2323; Fax: 949-824-4165.

References 

  1. US Census Bureau. Population projections (middle series). United States. 2002;Available at: www.census.gov.
  2. Evans DA, Funkenstein HH, Albert MS, Sher PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer’s disease in a community population of older persons: higher than previously reported. JAMA. 1989;262:2551–2556
  3. Miech RA, Breitner JCS, Zandi PP, Khachaturian AS, Anthony JC, Mayer L. Incidence of AD may decline in the early 90’s for men, later for women (The Cache County Study). Neurology. 2002;58:209–218
  4. Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference?. Neurobiol Aging. 2001;22:575–580
  5. Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002;59:1589–1593
  6. Hall CB, Verghese J, Sliwinski M, Chen Z, Katz M, Derby C, et al. Dementia incidence may increase more slowly after age 90: results from the Bronx Aging Study. Neurology. 2005;65:882–886
  7. Berlau D, Corrada M, Paganini-Hill A, Brookmeyer R, Kawas C. Incidence of dementia continues to increase after age 90: results from the 90+ Study. Neurology. 2007;68(Suppl 1):S01.003
  8. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA. 1998;279:688–695
  9. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA. 2002;288:2123–2129
  10. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001;58:498–504
  11. Lytle ME, Vander Bilt J, Pandav RS, Dodge HH, Ganguli M. Exercise level and cognitive decline: the MoVIES Project. Alzheimer Dis Assoc Disord. 2004;18:57–64
  12. Paganini-Hill A, Corrada MM, Kawas CH. Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study. Menopause. 2006;13:12–18
  13. Kawas C, Corrada M, Paganini-Hill A. Low weight in early adulthood and later life exercise increase chances of surviving to age 90. Neurology. 2003;60(Suppl 2):S58.002
  14. Wilson RS, Bienias JL, Evans DA, Bennett DA. The Religious Orders Study: overview and relation between change in cognitive and motor speed. Aging Neuropsychol Cogn. 2004;11:280–303
  15. Wang L, Larson EB, Bowen JD, van Belle G. Performance-based physical function and future dementia in older people. Arch Intern Med. 2006;166:1115–1120
  16. Corrada M, Head E, Kim R, Kawas C. Braak and Braak staging and dementia in the oldest-old: Preliminary results from the 90+ Study. Neurology. 2005;64(Suppl 1):A276
  17. Polvikoski T, Sulkava R, Myllykangas L, Notkola I, Niinistro L, Verkkoniemi A, et al. Prevalence of Alzheimer’s disease in very elderly people: a prospective neuropathological study. Neurology. 2001;56:1690–1696
  18. Crystal HA, Dickson D, Davies P, Masur D, Grober E, Lipton RB. The relative frequency of “dementia of unknown etiology” increases with age and is nearly 50% in nonagenarians. Arch Neurol. 2000;57:713–719
  19. Katzman R, Terry RD, DeTeresa R, Brown T, Davies P, Fuld P, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 1988;23:138–144
  20. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer’s disease. Neurology. 1988;38:1682–1687
  21. Silver MH, Newell K, Brady C, Hedley-White ET, Perls TT. Distinguishing between neurodegenerative disease and disease-free aging: correlating neuropsychological evaluations and neuropathological studies in centenarians. Psychosom Med. 2002;64:493–501
  22. Berlau DJ, Kahle-Wrobleski K, Head E, Goodus M, Kim R, Kawas C. Dissociation of neuropathologic findings and cognition: case report of an apolipoprotein E epsilon 2/epsilon 2 genotype. Arch Neurol. 2007;64:1193–1196
  23. Head E, Corrada M, Nistor M, Kawas C. Higher levels of synaptophysin, but not GAP-43 protein are associated with intact cognitive function in the oldest-old: the 90+ Study. Neurology. 2006;66(Suppl 2):P05.974, A279
  24. Corrada MM, Kawas CH, Mozaffar F, Paganini-Hill A. Association of body mass index and weight change with all-cause mortality in the elderly. Am J Epidemiol. 2006;163:938–949
  25. Paganini-Hill A, Kawas C, Corrada M. Type of alcohol consumed, changes in intake over time and mortality: the Leisure World Cohort Study. Age Ageing. 2007;36:203–209
  26. Paganini-Hill A, Kawas C, Corrada M. Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study. Prev Med. 2007;44:305–310
  27. Corrada M, Paganini-Hill A, Kawas C. Intake of antioxidant vitamins, calcium, beverages and mortality: the 90+ Study. Neurology. 2004;62(Suppl 5):

PII: S1552-5260(07)00646-2

doi: 10.1016/j.jalz.2007.11.007

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 4, Issue 1, Supplement 1 , Pages S56-S59 , January 2008

Article Tools

* Image Usage & Resolution